secwatch / observer
8-K filed June 28, 2024, 7:59 PM ET ticker HFFG CIK 0001680873
leadership confidence high sentiment neutral materiality 0.55

HF Foods appoints Maria Ross to board; Dr. Hong Wang resigns

HF Foods Group Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Maria Ross

Director
HFFG · HF Foods Group Inc.
Effective
2024-06-28
Filed
June 28, 2024, 7:59 PM ET
Effective June 28, 2024, the Board, upon the recommendation of its Nominating and Governance Committee, appointed Ms. Maria Ross as a member of the Board.
Departed

Dr. Hong Wang

Director
HFFG · HF Foods Group Inc.
Effective
2024-06-28
Filed
June 28, 2024, 7:59 PM ET
On June 25, 2024, Dr. Hong Wang informed the Board of Directors (the “Board”) of HF Foods Group Inc. (the “Company”) of his intention to resign from the Board and all committees thereof, effective June 28, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Maria Ross was appointed as Director at HF Foods Group Inc..

Action
appointed
Role
Director
Exact text from the filing
Effective June 28, 2024, the Board, upon the recommendation of its Nominating and Governance Committee, appointed Ms. Maria Ross as a member of the Board.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Dr. Hong Wang resigned as Director at HF Foods Group Inc..

Action
resigned
Role
Director
Exact text from the filing
On June 25, 2024, Dr. Hong Wang informed the Board of Directors (the “Board”) of HF Foods Group Inc. (the “Company”) of his intention to resign from the Board and all committees thereof, effective June 28, 2024.
View on SEC.gov

HF Foods Group Inc. filing history →

Source: SEC EDGAR
accession 0001680873-24-000044
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.